malaria: v_malaria_current: 244 rows sorted by display

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

244 rows sorted by display_name

descending

country_id	iso3	iso2	display_name ▼	has_transmission	is_endemic	whole_country_endemic	country_has_any_prophylaxis_area	screening_class	area_summary	species_json	prophylaxis_drugs_json	chloroquine_resistant	area_of_risk_html	recommended_prophylaxis_html	species_html	chloroquine_resist_html	cdc_updated_date	first_seen_on	record_id
115	AFG	AF	Afghanistan	1	1	1	1	whole_country	All areas <2,500 m (<8,200 ft) elevation (April–December)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All areas <2,500 m (<8,200 ft) elevation (April–December)	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. vivax (primarily) P. falciparum (less commonly)	Chloroquine	2025-04-23	2026-06-03	115
180	ALB	AL	Albania	0	0	0	0	none		[]	[]							2026-06-03	180
1	DZA	DZ	Algeria	0	0	0	0	none		[]	[]							2026-06-03	1
135	ASM	AS	American Samoa (U.S.)	0	0	0	0	none		[]	[]							2026-06-03	135
208	AND	AD	Andorra	0	0	0	0	none		[]	[]							2026-06-03	208
26	AGO	AO	Angola	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	26
59	AIA	AI	Anguilla (U.K.)	0	0	0	0	none		[]	[]							2026-06-03	59
235	ATA	AQ	Antarctica	0	0	0	0	none		[]	[]							2026-06-03	235
60	ATG	AG	Antigua and Barbuda	0	0	0	0	none		[]	[]							2026-06-03	60
101	ARG	AR	Argentina	0	0	0	0	none		[]	[]							2026-06-03	101
181	ARM	AM	Armenia	0	0	0	0	none		[]	[]							2026-06-03	181
61	ABW	AW	Aruba (Netherlands)	0	0	0	0	none		[]	[]							2026-06-03	61
136	AUS	AU	Australia	0	0	0	0	none		[]	[]							2026-06-03	136
209	AUT	AT	Austria	0	0	0	0	none		[]	[]							2026-06-03	209
182	AZE	AZ	Azerbaijan	0	0	0	0	none		[]	[]							2026-06-03	182
210	PRT	PT	Azores (Portugal)	0	0	0	0	none		[]	[]							2026-06-03	210
62	BHS	BS	Bahamas, The	0	0	0	0	none		[]	[]							2026-06-03	62
165	BHR	BH	Bahrain	0	0	0	0	none		[]	[]							2026-06-03	165
116	BGD	BD	Bangladesh	1	1	0	1	partial	1 risk area statement(s); 1 no-transmission exclusion(s)	["P. falciparum", "P. malariae", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	Districts of Chittagong Hill Tract (Bandarban, Khagrachari, and Rangamati); and the following districts: Chattogram (Chittagong) and Cox’s Bazar (in Chattogram [Chittagong] Division); Mymensingh, Netrakona, and Sherpur (in Mymensingh Division); Kurigram (in Rangpur Division); Habiganj, Moulvibazar, Sunamganj, and Sylhet (in Sylhet Division) No malaria transmission in Dhaka (the capital)	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (80%) P. vivax (20%) P. malariae (rare)	Chloroquine	2025-04-23	2026-06-03	116
63	BRB	BB	Barbados	0	0	0	0	none		[]	[]							2026-06-03	63
183	BLR	BY	Belarus	0	0	0	0	none		[]	[]							2026-06-03	183
211	BEL	BE	Belgium	0	0	0	0	none		[]	[]							2026-06-03	211
83	BLZ	BZ	Belize	0	0	0	0	none		[]	[]							2026-06-03	83
8	BEN	BJ	Benin	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	8
64	BMU	BM	Bermuda (U.K.)	0	0	0	0	none		[]	[]							2026-06-03	64
117	BTN	BT	Bhutan	1	0	0	0	none	Transmission present; no chemoprophylaxis recommended (mosquito avoidance only).	["P. falciparum", "P. vivax"]	[]	1	Rare cases in rural areas <1,700 m (<5,500 ft) elevation in districts along the southern border shared with India	None (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. vivax (primarily) P. falciparum (less commonly)	Chloroquine	2025-04-23	2026-06-03	117
91	BOL	BO	Bolivia	1	1	0	1	partial	1 risk area statement(s); 1 no-transmission exclusion(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "primaquine", "tafenoquine"]	1	All areas <2,500 m (<8,200 ft) elevation No malaria transmission in La Paz (administrative capital)	Atovaquone-proguanil, doxycycline, mefloquine, primaquine⁵, tafenoquine² Updated April 23, 2025	P. vivax (99%) P. falciparum (1%)	Chloroquine	2025-04-23	2026-06-03	91
238	BES	BQ	Bonaire (Netherlands)	0	0	0	0	none		[]	[]							2026-06-03	238
184	BIH	BA	Bosnia and Herzegovina	0	0	0	0	none		[]	[]							2026-06-03	184
53	BWA	BW	Botswana	1	1	0	1	partial	2 risk area statement(s); 1 no-transmission exclusion(s)	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	Districts/subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North-East (including its capital, Francistown), Okavango, Serowe/Palapye, and Tutume Rare cases or sporadic foci of transmission in districts/subdistricts of Kgalagadi North, Kgatleng, Kweneng, and Southern No malaria transmission in Gaborone (the capital)	Districts/subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North-East (including its capital, Francistown), Okavango, Serowe/Palapye, and Tutume: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Areas with rare cases or sporadic foci of transmission: no chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	53
92	BRA	BR	Brazil	1	1	0	1	partial	3 risk area statement(s); 2 no-transmission exclusion(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All areas in the states of Acre, Amapá, Amazonas, Rondônia, and Roraima Present in the states of Maranhão, Mato Grosso, and Pará, but rare cases in their capital cities (São Luis [capital of Maranhão], Cuiabá [capital of Mato Grosso], Belém [capital of Pará]) Rare cases and sporadic foci of transmission in rural and forested areas in the states of Espírito Santo, Goiás, Minas Gerais, Mato Grosso do Sul, Piauí, Rio de Janeiro, São Paolo, and Tocantins No malaria transmission in the cities of Brasília (the capital), Rio de Janeiro, or São Paolo No malaria transmission at Iguaçu Falls	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Areas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. vivax (90%) P. falciparum (10%)	Chloroquine	2025-04-23	2026-06-03	92
118	IOT	IO	British Indian Ocean Territory; includes Diego Garcia (U.K.)	0	0	0	0	none		[]	[]							2026-06-03	118
124	BRN	BN	Brunei	1	0	0	0	none	Transmission present; no chemoprophylaxis recommended (mosquito avoidance only).	["P. knowlesi"]	[]	0	Rare transmission of P. knowlesi⁶ in primarily forested or forest-fringe areas	None (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. knowlesi⁶ (100%)	None	2025-04-23	2026-06-03	124
185	BGR	BG	Bulgaria	0	0	0	0	none		[]	[]							2026-06-03	185
9	BFA	BF	Burkina Faso	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	9
125	MMR	MM	Burma (Myanmar)	1	1	1	1	whole_country	All areas	["P. falciparum", "P. knowlesi", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All areas	Areas in the regions of Bago and Tanintharyi; and in the states of Kachin, Kayah, Kayin, and Shan: Atovaquone-proguanil, doxycycline, tafenoquine² All other areas: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. vivax (80%) P. falciparum (20%) P. knowlesi,⁶ P. malariae, and P. ovale (rare)	Chloroquine and mefloquine	2025-04-23	2026-06-03	125
36	BDI	BI	Burundi	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	36
126	KHM	KH	Cambodia	1	1	0	1	partial	4 risk area statement(s)	["P. falciparum", "P. knowlesi", "P. malariae", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "primaquine", "tafenoquine"]	1	Primarily isolated to pockets in rural and forested areas Rare cases in non-forested areas No (or negligible) malaria transmission in the cities of Phnom Penh (the capital) and Siem Reap No (or negligible) malaria transmission at the main temple complex at Angkor Wat	Rural and forested areas: Atovaquone-proguanil, doxycycline, primaquine⁵, tafenoquine² Areas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. vivax (95%) P. falciparum (5%) P. malariae and P. knowlesi⁶ (rare)	Chloroquine and mefloquine	2025-04-23	2026-06-03	126
27	CMR	CM	Cameroon	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	27
162	CAN	CA	Canada	0	0	0	0	none		[]	[]							2026-06-03	162
2	ESP	ES	Canary Islands ( Spain )	0	0	0	0	none		[]	[]							2026-06-03	2
10	CPV	CV	Cape Verde	0	0	0	0	none		[]	[]							2026-06-03	10
65	CYM	KY	Cayman Islands (U.K.)	0	0	0	0	none		[]	[]							2026-06-03	65
28	CAF	CF	Central African Republic	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	28
29	TCD	TD	Chad	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	29
102	CHL	CL	Chile	0	0	0	0	none		[]	[]							2026-06-03	102
107	CHN	CN	China	0	0	0	0	none		[]	[]							2026-06-03	107
137	CXR	CX	Christmas Island (Australia)	0	0	0	0	none		[]	[]							2026-06-03	137
138	CCK	CC	Cocos (Keeling) Islands (Australia)	0	0	0	0	none		[]	[]							2026-06-03	138
93	COL	CO	Colombia	1	1	0	1	partial	1 risk area statement(s); 1 no-transmission exclusion(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All areas <1,700 m (<5,600 ft) elevation No malaria transmission in the cities of Bogotá (the capital), Cartagena, or Medellín	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (50%) P. vivax (50%)	Chloroquine	2025-04-23	2026-06-03	93
37	COM	KM	Comoros	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae and P. vivax (rare)	Chloroquine	2025-04-23	2026-06-03	37
30	COG	CG	Congo, Republic of the (Congo-Brazzaville)	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	30
139	COK	CK	Cook Islands (New Zealand)	0	0	0	0	none		[]	[]							2026-06-03	139
84	CRI	CR	Costa Rica	1	1	0	1	partial	2 risk area statement(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "chloroquine", "doxycycline", "mefloquine", "tafenoquine"]	0	Present in the provinces of Alajuela and Limón Rare to no transmission in other parts of the country	Alajuela and Limón Provinces: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine² All other areas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. falciparum (86%) P. vivax (14%)	None	2025-04-23	2026-06-03	84
186	HRV	HR	Croatia	0	0	0	0	none		[]	[]							2026-06-03	186
66	CUB	CU	Cuba	0	0	0	0	none		[]	[]							2026-06-03	66
239	CUW	CW	Curaçao (Netherlands)	0	0	0	0	none		[]	[]							2026-06-03	239
166	CYP	CY	Cyprus	0	0	0	0	none		[]	[]							2026-06-03	166
187	CZE	CZ	Czechia (Czech Republic)	0	0	0	0	none		[]	[]							2026-06-03	187
11	CIV	CI	Côte d'Ivoire (Ivory Coast)	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	11
31	COD	CD	Democratic Republic of the Congo (Congo-Kinshasa)	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	31
212	DNK	DK	Denmark	0	0	0	0	none		[]	[]							2026-06-03	212
38	DJI	DJ	Djibouti	1	1	1	1	whole_country	All	["P. falciparum", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (60–70%) P. vivax (30–40%) P. ovale (rare)	Chloroquine	2025-04-23	2026-06-03	38
67	DMA	DM	Dominica	0	0	0	0	none		[]	[]							2026-06-03	67
68	DOM	DO	Dominican Republic	1	1	0	1	partial	3 risk area statement(s)	["P. falciparum"]	["atovaquone-proguanil", "chloroquine", "doxycycline", "mefloquine", "tafenoquine"]	0	Primarily in the provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo In the Distrito Nacional, city of Santo Domingo (the capital), primarily in the La Ciénaga and Los Tres Brazos areas Rare transmission in other provinces	Provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine² All other areas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. falciparum (100%)	None	2025-04-23	2026-06-03	68
103	CHL	CL	Easter Island (Chile)	0	0	0	0	none		[]	[]							2026-06-03	103
94	ECU	EC	Ecuador, including the Galápagos Islands	1	1	0	1	partial	2 risk area statement(s); 2 no-transmission exclusion(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	Areas <1,500 m (<5,000 ft) elevation in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos Rare cases <1,500 m (<5,000 ft) in all other provinces No malaria transmission in the cities of Guayaquil or Quito (the capital) No malaria transmission on the Galápagos Islands	Transmission areas in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² All other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. vivax (85%) P. falciparum (15%)	Chloroquine	2025-04-23	2026-06-03	94
3	EGY	EG	Egypt	0	0	0	0	none		[]	[]							2026-06-03	3
85	SLV	SV	El Salvador	0	0	0	0	none		[]	[]							2026-06-03	85
32	GNQ	GQ	Equatorial Guinea	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	32
39	ERI	ER	Eritrea	1	1	0	1	partial	1 risk area statement(s); 1 no-transmission exclusion(s)	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All areas <2,200 m (<7,200 ft) elevation No malaria transmission in Asmara (the capital)	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (80–85%) P. vivax (15–20%) P. malariae and P. ovale (rare)	Chloroquine	2025-04-23	2026-06-03	39
188	EST	EE	Estonia	0	0	0	0	none		[]	[]							2026-06-03	188
57	SWZ	SZ	Eswatini (Swaziland)	1	1	0	1	partial	1 risk area statement(s)	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	Eastern areas bordering Mozambique and South Africa, including the entire region of Lubombo and the eastern half of Hhohho, Manzini, and Shiselweni Regions	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	57
40	ETH	ET	Ethiopia	1	1	1	1	whole_country	All areas <2,500 m (<8,200 ft) elevation	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All areas <2,500 m (<8,200 ft) elevation	All areas <2,500m (8,200 ft) elevation, including Addis Ababa: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (70%) P. vivax (30%) P. malariae and P. ovale (rare)	Chloroquine	2025-04-23	2026-06-03	40
104	FLK	FK	Falkland Islands (Islas Malvinas), UK Overseas Territory (also claimed by Argentina)	0	0	0	0	none		[]	[]							2026-06-03	104
213	FRO	FO	Faroe Islands (Denmark)	0	0	0	0	none		[]	[]							2026-06-03	213
140	FJI	FJ	Fiji	0	0	0	0	none		[]	[]							2026-06-03	140
214	FIN	FI	Finland	0	0	0	0	none		[]	[]							2026-06-03	214
215	FRA	FR	France	0	0	0	0	none		[]	[]							2026-06-03	215
95	GUF	GF	French Guiana	1	1	0	1	partial	1 risk area statement(s); 2 no-transmission exclusion(s)	["P. falciparum", "P. malariae", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	Areas associated with gold mining, primarily the communes near the border with Brazil and Suriname, especially Régina and Saint-Georges-de-l’Oyapock; also, the communes of Kourou, Matoury, and Saint-Élie No malaria transmission in coastal areas west of Kourou No malaria transmission in Cayenne City (the capital)	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. vivax (85%) P. falciparum (15%) P. malariae (rare)	Chloroquine	2025-04-23	2026-06-03	95
141	PYF	PF	French Polynesia (France), including the Society Islands [Bora-Bora, Moorea & Tahiti]; Marquesas Islands [Hiva Oa & Ua Huka]; and Austral Islands (Tubuai & Rurutu)	0	0	0	0	none		[]	[]							2026-06-03	141
33	GAB	GA	Gabon	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	33
12	GMB	GM	Gambia, The	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	12
189	GEO	GE	Georgia	0	0	0	0	none		[]	[]							2026-06-03	189
216	DEU	DE	Germany	0	0	0	0	none		[]	[]							2026-06-03	216
13	GHA	GH	Ghana	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	13
217	GIB	GI	Gibraltar (U.K.)	0	0	0	0	none		[]	[]							2026-06-03	217
218	GRC	GR	Greece	1	0	0	0	none	Transmission present; no chemoprophylaxis recommended (mosquito avoidance only).	["P. vivax"]	[]		Rare, local transmission in agricultural areas, associated with imported malaria (May–November) No malaria transmission in tourist areas	None Updated April 23, 2025	P. vivax (100%)	Not applicable	2025-04-23	2026-06-03	218
219	GRL	GL	Greenland (Denmark)	0	0	0	0	none		[]	[]							2026-06-03	219
69	GRD	GD	Grenada	0	0	0	0	none		[]	[]							2026-06-03	69
70	GLP	GP	Guadeloupe (including Marie-Galante, La Désirade & Îles des Saintes)	0	0	0	0	none		[]	[]							2026-06-03	70
142	GUM	GU	Guam (U.S.)	0	0	0	0	none		[]	[]							2026-06-03	142
86	GTM	GT	Guatemala	1	1	0	1	partial	2 risk area statement(s); 2 no-transmission exclusion(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "chloroquine", "doxycycline", "mefloquine", "primaquine", "tafenoquine"]	0	Primarily in the departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén Few cases reported in other departments No malaria transmission in the cities of Antigua or Guatemala City (the capital) No malaria transmission at Lake Atitlán	Departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine⁵, tafenoquine² Other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. vivax (99%) P. falciparum (1%)	None	2025-04-23	2026-06-03	86
14	GIN	GN	Guinea	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	14
15	GNB	GW	Guinea-Bissau	1	1	1	1	whole_country	All	["P. falciparum", "P. malariae", "P. ovale", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All	Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (primarily) P. malariae, P. ovale, and P. vivax (less commonly)	Chloroquine	2025-04-23	2026-06-03	15
96	GUY	GY	Guyana	1	1	0	1	partial	All	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"]	1	All Rare cases in the cities of Georgetown (the capital) and New Amsterdam	All areas (except the cities of Georgetown and New Amsterdam): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine² Cities of Georgetown and Amsterdam: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)⁴ Updated April 23, 2025	P. vivax (60%) P. falciparum (40%)	Chloroquine	2025-04-23	2026-06-03	96
71	HTI	HT	Haiti	1	1	1	1	whole_country	All (including Labadee, also known as Port Labadee)	["P. falciparum", "P. malariae"]	["atovaquone-proguanil", "chloroquine", "doxycycline", "mefloquine", "tafenoquine"]	0	All (including Labadee, also known as Port Labadee)	Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. falciparum (99%) P. malariae (rare)	None	2025-04-23	2026-06-03	71
87	HND	HN	Honduras	1	1	0	1	partial	1 risk area statement(s); 1 no-transmission exclusion(s)	["P. falciparum", "P. vivax"]	["atovaquone-proguanil", "chloroquine", "doxycycline", "mefloquine", "tafenoquine"]	0	Throughout the country and on the island of Roatán and other Bay Islands No malaria transmission in the cities of San Pedro Sula or Tegucigalpa (the capital)	Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine² Updated April 23, 2025	P. vivax (70%) P. falciparum (30%)	None	2025-04-23	2026-06-03	87
108	HKG	HK	Hong Kong (China)	0	0	0	0	none		[]	[]							2026-06-03	108
190	HUN	HU	Hungary	0	0	0	0	none		[]	[]							2026-06-03	190

Advanced export

JSON shape: default, array, newline-delimited

CREATE VIEW v_malaria_current AS
SELECT
  c.country_id, c.iso3, c.iso2, c.display_name,
  mr.has_transmission, mr.is_endemic, mr.whole_country_endemic,
  mr.country_has_any_prophylaxis_area, mr.screening_class,
  mr.area_summary, mr.species_json, mr.prophylaxis_drugs_json, mr.chloroquine_resistant,
  mr.area_of_risk_html, mr.recommended_prophylaxis_html, mr.species_html, mr.chloroquine_resist_html,
  mr.cdc_updated_date, mr.valid_from AS first_seen_on, mr.record_id
FROM malaria_record mr
JOIN country c USING (country_id)
WHERE mr.is_current = 1;

Current malaria status (one row per country) (view)

244 rows sorted by display_name

Advanced export